The Motley Fool

This UK growth stock is rocketing. Is there still time to buy?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Senior Man Sitting On Sofa At Home With Pet Labrador Dog
Image source: Getty Images

Today’s trading statement from veterinary services provider CVS Group (LSE: CVSG) goes some way to explaining why its share price has been hitting record highs recently. While this may prompt some investors to take profits after a strong run, I would see no reason to back out just yet if I did hold it. In fact, I think the huge increase in UK pet ownership over the last year means there could be even more upside ahead for this growth stock. 

Strong revenue growth

As one of the biggest vets businesses in the UK, it’s not surprising that business at CVS has boomed the last year or so. Positively, it would seem that this trading momentum has been particularly evident over the last couple of months. “Strong revenue growth” was achieved in May and June, according to the company.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

As far as actual numbers were concerned, like-for-like sales growth for the financial year to the end of June came in at 17.4%. This was clearly far better than the meagre 0.7% achieved last year. Then again, like so many other businesses, CVS Group was massively affected by the introduction of Covid-19 restrictions. 

The firm now expects to report EBITDA (earnings before interest, tax, depreciation, and amortisation) “marginally ahead” of what analysts were expecting. 

But can all this last?

I think this can last. Although we now appear to be coming to the final few chapters of the pandemic, all those new pet dogs, cats, and iguanas will need regular checkups for many years afterward. This demand should provide some support to the CVS share price going forward.

In another sign of just how much the trading environment has improved, CVS said today that it now employs roughly 10% more vets compared to this time last year. It’s also advertising for new positions and planning to continue its acquisition-friendly strategy by snapping up independent practices. That sounds pretty bullish to me!

Buyer beware

If all this sounds like I think the shares of CVS can only go way, let me clear: I think there are still risks to investing here.

One I’ve already mentioned is the possibility of profit-taking in the months ahead. ‘Running your winners’ is a rule of thumb that I endorse. However, there will come a time when some long-term holders will want to move on. After all, the shares have climbed 116% over the last year. Anyone buying when this growth stock dipped to a low of 433p back in February 2019 would have a gain of over 400% by now.

At 31 times FY22 earnings, the valuation undoubtedly reflects this. One needs to remember that CVS isn’t the only veterinary services provider out there. So, while there may be more pet owners these days, it’s clear the company can’t rest on its laurels. Client numbers must keep rising.

Ongoing recruitment also has implications for the mid-cap’s bottom line. A shortage of vets and support staff will mean that CVS needs to make its pay and perks more attractive to get the best talent.

Defensive growth stock

So long as I were comfortable with the drawbacks of investing in CVS right now, I’d buy this defensive growth stock today. Regardless of what happens next in the economy, people won’t stop spending cash on their furry (and not so furry) companions. To me, that makes for a compelling investment

One FTSE “Snowball Stock” With Runaway Revenues

Looking for new share ideas?

Grab this FREE report now.

Inside, you discover one FTSE company with a runaway snowball of profits.

From 2015-2019…

  • Revenues increased 38.6%.
  • Its net income went up 19.7 times!
  • Since 2012, revenues from regular users have almost DOUBLED

The opportunity here really is astounding.

In fact, one of its own board members recently snapped up 25,000 shares using their own money...

So why sit on the side lines a minute longer?

You could have the full details on this company right now.

Grab your free report – while it’s online.

Paul Summers has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply click below to discover how you can take advantage of this.